MedElevator Войти в исследования
← Поиск публикаций

DOI 10.24875/gmm.m22000804

Медицинская библиотека · Gaceta medica de Mexico · 2022

Myelofibrosis: diagnosis and treatment.

Barranco-Lampón Gilberto, Martínez-Castro Raúl, Arana-Luna Luara, Álvarez-Vera José Luis, Rojas-Castillejos Flavio, Peñaloza-Ramírez Rosalinda, Carballo-Zarate Adrián Alejandro, Olarte-Carrillo Irma, Minamy Jaime Israel-García, López-Salazar Javier, Navarrete Juan José, Espinosa-Partida Arturo, Ventura-Enríquez Yanet, Ruiz-Contreras Josué Isel, Aguirre-Reyes Oyuky Gissell, Anaya-Cuéllar Irene, Aguilar-Luévano Jocelyn, Díaz-Ramírez Hugo Francisco, Herrera-Olivares Wilfrido, Aguilar-Hidalgo José Antonio, Alcívar-Cedeño Luisa Ma, Hernández-Caballero Álvaro, Galaz-Cordero Lourdes Elena, Peña-Celaya José Antonio de la, Báez-Islas Pamela Elena, Bates-Martín Ramón Alberto, Cano-León Ana Ma de la Luz, Espitia-Ríos Ma Eugenia, Barbosa Diego, Morales-Adrián Javier, Pacheco Martín Jacobo, Delgado-López Nancy, Neme-Yunes Yvette, Moralws-Hernández Alba Edna, Mújica-Martínez Aldo, Pérez-Lizardi Alejandra Betsabé, Pérez-Gómez Karen Daniela, Barragán-Ibáñez Gabriel, Martínez Adolfo, Flores-Ordúñez Karen, Ramírez-Hoyos Paulina, Rosales-López Ma de Los Ángeles, Acosta-Maldonado Brenda Lizeth, Jiménez-Ochoa Marco Alejandro, Garzón-Velásquez Katheryn Betsabé, Hernández-Ruiz Eleazar, McNally-Guillén Bosco Martín, Saucedo-Montes Erick Eduardo, Aguilar-Andrade Carolina, Vivas-Arteaga Cindy Lissette, Guerra-Alarcón Lidia Virginia, Milán-Salvatierra Andrea Iracema, Campa-Monroy Dafne Itzel, Cota-Rangel Xóchitl, Estrada-Domínguez Patricia, García-Camacho Alinka Socorro, García-Castillo Carolina, Banda-García Luisa Iztacihuatl, Rodríguez-Sánchez Vania, Meillón-García Luis Antonio, Urbina-Escalante Elizabeth, Martínez-Ramírez Mario Alberto, Loera-Fragoso Sergio José, Martínez-Coronel Jorge, Zapata-Canto Nidia, Gómez-Cortés Sue Cynthia, Medina-Coral Jesús Emanuel, Mójica-Balderas Liliana, Pérez-Zúñiga Juan Manuel, Pérez Fernando Jacobo, López-Arroyo José Luis, Zazueta-Pozos Juan Francisco, Romero-Martínez Eduardo, Romero-Rodelo Hilda, Tapia-Enríquez Ana Laura, Soriano-Mercedes Emely Johanny, Salazar-Ramírez Óscar, Vilchis-González Shendel Paulina, Tepepa-Flores Fredy, Alvarado-Ibarra Martha

СтатьяПеревод в очереди

Аннотация

Myelofibrosis (MF) is a BCR-ABL1-negative myeloproliferative neoplasm characterized by clonal myeloproliferation, dysregulated kinase signaling, and release of abnormal cytokines. In recent years, important progress has been made in the knowledge of the molecular biology and the prognostic assessment of MF. Conventional treatment has limited impact on the patients' survival; it includes a wait-and-see approach for asymptomatic patients, erythropoiesis-stimulating agents, androgens, or immunomodulatory agents for anemia, cytoreductive drugs such as hydroxyurea for the splenomegaly and constitutional symptoms, and splenectomy or radiotherapy in selected patients. The discovery of the Janus kinase (JAK) 2 mutation triggered the development of molecular targeted therapy of MF. The JAK inhibitors are effective in both JAK2-positive and JAK2-negative MF; one of them, ruxolitinib, is the current best available therapy for MF splenomegaly and constitutional symptoms. Although ruxolitinib has changed the therapeutic scenario of MF, there is no clear indication of a disease-modifying effect. Allogeneic stem cell transplantation remains the only curative therapy of MF, but due to its associated morbidity and mortality, it is usually restricted to eligible high- and intermediate-2-risk MF patients. To improve current therapeutic results, the combination of JAK inhibitors with other agents is currently being tested, and newer drugs are being investigated.

Для цитирования: Barranco-Lampón Gilberto, Martínez-Castro Raúl, Arana-Luna Luara, Álvarez-Vera José Luis, Rojas-Castillejos Flavio, Peñaloza-Ramírez Rosalinda, Carballo-Zarate Adrián Alejandro, Olarte-Carrillo Irma, Minamy Jaime Israel-García, López-Salazar Javier, Navarrete Juan José, Espinosa-Partida Arturo, Ventura-Enríquez Yanet, Ruiz-Contreras Josué Isel, Aguirre-Reyes Oyuky Gissell, Anaya-Cuéllar Irene, Aguilar-Luévano Jocelyn, Díaz-Ramírez Hugo Francisco, Herrera-Olivares Wilfrido, Aguilar-Hidalgo José Antonio, Alcívar-Cedeño Luisa Ma, Hernández-Caballero Álvaro, Galaz-Cordero Lourdes Elena, Peña-Celaya José Antonio de la, Báez-Islas Pamela Elena, Bates-Martín Ramón Alberto, Cano-León Ana Ma de la Luz, Espitia-Ríos Ma Eugenia, Barbosa Diego, Morales-Adrián Javier, Pacheco Martín Jacobo, Delgado-López Nancy, Neme-Yunes Yvette, Moralws-Hernández Alba Edna, Mújica-Martínez Aldo, Pérez-Lizardi Alejandra Betsabé, Pérez-Gómez Karen Daniela, Barragán-Ibáñez Gabriel, Martínez Adolfo, Flores-Ordúñez Karen, Ramírez-Hoyos Paulina, Rosales-López Ma de Los Ángeles, Acosta-Maldonado Brenda Lizeth, Jiménez-Ochoa Marco Alejandro, Garzón-Velásquez Katheryn Betsabé, Hernández-Ruiz Eleazar, McNally-Guillén Bosco Martín, Saucedo-Montes Erick Eduardo, Aguilar-Andrade Carolina, Vivas-Arteaga Cindy Lissette, Guerra-Alarcón Lidia Virginia, Milán-Salvatierra Andrea Iracema, Campa-Monroy Dafne Itzel, Cota-Rangel Xóchitl, Estrada-Domínguez Patricia, García-Camacho Alinka Socorro, García-Castillo Carolina, Banda-García Luisa Iztacihuatl, Rodríguez-Sánchez Vania, Meillón-García Luis Antonio, Urbina-Escalante Elizabeth, Martínez-Ramírez Mario Alberto, Loera-Fragoso Sergio José, Martínez-Coronel Jorge, Zapata-Canto Nidia, Gómez-Cortés Sue Cynthia, Medina-Coral Jesús Emanuel, Mójica-Balderas Liliana, Pérez-Zúñiga Juan Manuel, Pérez Fernando Jacobo, López-Arroyo José Luis, Zazueta-Pozos Juan Francisco, Romero-Martínez Eduardo, Romero-Rodelo Hilda, Tapia-Enríquez Ana Laura, Soriano-Mercedes Emely Johanny, Salazar-Ramírez Óscar, Vilchis-González Shendel Paulina, Tepepa-Flores Fredy, Alvarado-Ibarra Martha. Myelofibrosis: diagnosis and treatment.. Gaceta medica de Mexico. 2022. DOI: 10.24875/gmm.m22000804.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.